$1.16
+0.02 (+1.32%)
Open$1.16
Previous Close$1.14
Day High$1.16
Day Low$1.14
52W High$2.62
52W Low$0.81
Volume—
Avg Volume862.5K
Market Cap195.44M
P/E Ratio1.05
EPS$1.67
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+3,034.2% upside
Current
$1.16
$1.16
Target
$36.20
$36.20
$24.75
$36.20 avg
$54.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 50.99M | 87.20M | 45.49M |
| Net Income | 203.13M | 312.67M | -11,017,037 |
| Profit Margin | 398.4% | 378.5% | -24.2% |
| EBITDA | -214,251,626 | -348,108,508 | -13,211,435 |
| Free Cash Flow | — | — | -11,236,120 |
| Rev Growth | -41.5% | -41.5% | +9.2% |
| Debt/Equity | 0.84 | 0.84 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |